Predisposition to cancer caused by genetic and functional defects of mammalian atad5

PLoS Genetics

Volumn 7, Issue 8, 2011, Pages

  Bell, Daphne W ^a   Sikdar, Nilabja ^a,b   Lee, Kyoo Young ^a   Price, Jessica C ^a   Chatterjee, Raghunath ^b   Park, Hee Dong ^a,c   Fox, Jennifer ^a   Ishiai, Masamichi ^d   Rudd, Meghan L ^a   Pollock, Lana M ^a   Fogoros, Sarah K ^a   Mohamed, Hassan ^a   Hanigan, Christin L ^a   NISC Comparative Sequencing Program, ^e   Zhang, Suiyuan ^a   Cruz, Pedro ^a   Renaud, Gabriel ^a   Hansen, Nancy F ^a   Cherukuri, Praveen F ^a   Borate, Bhavesh ^a   McManus, Kirk J ^f,i   Stoepel, Jan ^f   Sipahimalani, Payal ^f   Godwin, Andrew K ^g   Sgroi, Dennis C ^h   Merino, Maria J ^b   Elliot, Gene ^a   Elkahloun, Abdel ^a   Vinson, Charles ^b   Takata, Minoru ^d   Mullikin, James C ^a   Wolfsberg, Tyra G ^a   Hieter, Philip ^f   Lim, Dae Sik ^a,c   Myung, Kyungjae ^a   more..

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN ATAD5; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE; ATAD5 PROTEIN, HUMAN; CYCLINE; DNA BINDING PROTEIN;

ANEUPLOIDY; ANGIOSARCOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CARCINOMA; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; ENDOMETRIUM CANCER; FEMALE; GENETIC DISORDER; GENOMIC INSTABILITY; GRANULOSA CELL TUMOR; HAPLOINSUFFICIENCY; HUMAN; HUMAN CELL; LIMB TUMOR; LIVER CARCINOMA; LOSS OF FUNCTION MUTATION; LUNG ADENOCARCINOMA; MALE; MOUSE; NONHUMAN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVE TUMOR; SARCOMA; SMALL INTESTINE TUMOR; SOMATIC MUTATION; SPINDLE CELL CARCINOMA; STOMACH TUMOR; THYMOMA; UBIQUITINATION; UTERUS SARCOMA; ANIMAL; CELL LINE; CELL TRANSFORMATION; ENDOMETRIUM TUMOR; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; NEOPLASM;

MAMMALIA; MUS;

ADENOSINE TRIPHOSPHATASES; ANEUPLOIDY; ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOMIC INSTABILITY; HUMANS; MALE; MICE; MUTATION; NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; UBIQUITINATION;

EID: 80052318336     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002245     Document Type: Article

References (52)

1. Foijer F, (2010) CINister thoughts. Biochem Soc Trans 38: 1715-1721.
2. Holland AJ, Cleveland DW, (2009) Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 10: 478-487.
3. Huang ME, Rio AG, Nicolas A, Kolodner RD, (2003) A genomewide screen in Saccharomyces cerevisiae for genes that suppress the accumulation of mutations. Proc Natl Acad Sci U S A 100: 11529-11534.
4. Smith S, Hwang JY, Banerjee S, Majeed A, Gupta A, et al. (2004) Mutator genes for suppression of gross chromosomal rearrangements identified by a genome-wide screening in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 101: 9039-9044.
5. Yuen KW, Warren CD, Chen O, Kwok T, Hieter P, et al. (2007) Systematic genome instability screens in yeast and their potential relevance to cancer. Proc Natl Acad Sci U S A 104: 3925-3930.
6. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, et al. (2000) Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25: 144-146.
7. Padilla-Nash HM, Nash WG, Padilla GM, Roberson KM, Robertson CN, et al. (1999) Molecular cytogenetic analysis of the bladder carcinoma cell line BK-10 by spectral karyotyping. Genes Chromosomes Cancer 25: 53-59.
8. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, et al. (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20: 207-211.
9. Piper J, Rutovitz D, Sudar D, Kallioniemi A, Kallioniemi OP, et al. (1995) Computer image analysis of comparative genomic hybridization. Cytometry 19: 10-26.
10. Schrock E, Veldman T, Padilla-Nash H, Ning Y, Spurbeck J, et al. (1997) Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum Genet 101: 255-262.
11. Sprung CN, Afshar G, Chavez EA, Lansdorp P, Sabatier L, et al. (1999) Telomere instability in a human cancer cell line. Mutat Res 429: 209-223.
12. McLellan J, O'Neil N, Tarailo S, Stoepel J, Bryan J, et al. (2009) Synthetic lethal genetic interactions that decrease somatic cell proliferation in Caenorhabditis elegans identify the alternative RFC CTF18 as a candidate cancer drug target. Mol Biol Cell 20: 5306-5313.
13. McManus KJ, Barrett IJ, Nouhi Y, Hieter P, (2009) Specific synthetic lethal killing of RAD54B-deficient human colorectal cancer cells by FEN1 silencing. Proc Natl Acad Sci U S A 106: 3276-3281.
14. Banerjee S, Myung K, (2004) Increased genome instability and telomere length in the elg1-deficient Saccharomyces cerevisiae mutant are regulated by S-phase checkpoints. Eukaryot Cell 3: 1557-1566.
15. Bellaoui M, Chang M, Ou J, Xu H, Boone C, et al. (2003) Elg1 forms an alternative RFC complex important for DNA replication and genome integrity. EMBO J 22: 4304-4313.
16. Ben-Aroya S, Koren A, Liefshitz B, Steinlauf R, Kupiec M, (2003) ELG1, a yeast gene required for genome stability, forms a complex related to replication factor C. Proc Natl Acad Sci U S A 100: 9906-9911.
17. Kanellis P, Agyei R, Durocher D, (2003) Elg1 forms an alternative PCNA-interacting RFC complex required to maintain genome stability. Curr Biol 13: 1583-1595.
18. Sikdar N, Banerjee S, Lee KY, Wincovitch S, Pak E, et al. (2009) DNA damage responses by human ELG1 in S phase are important to maintain genomic integrity. Cell Cycle 8.
19. Lee KY, Yang K, Cohn MA, Sikdar N, D'Andrea AD, et al. (2010) Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1. J Biol Chem 285: 10362-10369.
20. Johnson RE, Kondratick CM, Prakash S, Prakash L, (1999) hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 285: 263-265.
21. Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, et al. (1999) The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399: 700-704.
22. Dertinger SD, Torous DK, Tometsko KR, (1996) Simple and reliable enumeration of micronucleated reticulocytes with a single-laser flow cytometer. Mutat Res 371: 283-292.
23. Ishii H, Inageta T, Mimori K, Saito T, Sasaki H, et al. (2005) Frag1, a homolog of alternative replication factor C subunits, links replication stress surveillance with apoptosis. Proc Natl Acad Sci U S A 102: 9655-9660.
24. Banerjee S, Sikdar N, Myung K, (2007) Suppression of gross chromosomal rearrangements by a new alternative replication factor C complex. Biochem Biophys Res Commun 362: 546-549.
25. Majka J, Burgers PM, (2004) The PCNA-RFC families of DNA clamps and clamp loaders. Prog Nucleic Acid Res Mol Biol 78: 227-260.
26. Smith GS, Walford RL, Mickey MR, (1973) Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids. J Natl Cancer Inst 50: 1195-1213.
27. Pradhan M, Abeler VM, Danielsen HE, Trope CG, Risberg BA, (2006) Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas. Mod Pathol 19: 1227-1235.
28. Davidson MB, Brown GW, (2008) The N- and C-termini of Elg1 contribute to the maintenance of genome stability. DNA Repair (Amst) 7: 1221-1232.
29. Schvartzman JM, Sotillo R, Benezra R, (2010) Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 10: 102-115.
30. Cassia R, Moreno-Bueno G, Rodriguez-Perales S, Hardisson D, Cigudosa JC, et al. (2003) Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma. J Pathol 201: 589-595.
31. Moreno-Bueno G, Sanchez-Estevez C, Cassia R, Rodriguez-Perales S, Diaz-Uriarte R, et al. (2003) Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res 63: 5697-5702.
32. Lax SF, Kendall B, Tashiro H, Slebos RJ, Hedrick L, (2000) The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer 88: 814-824.
33. Spruck CH, Strohmaier H, Sangfelt O, Muller HM, Hubalek M, et al. (2002) hCDC4 gene mutations in endometrial cancer. Cancer Res 62: 4535-4539.
34. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
35. Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, et al. (2008) Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A 105: 4283-4288.
36. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
37. Kim JM, Parmar K, Huang M, Weinstock DM, Ruit CA, et al. (2009) Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev Cell 16: 314-320.
38. Langerak P, Nygren AO, Krijger PH, van den Berk PC, Jacobs H, (2007) A/T mutagenesis in hypermutated immunoglobulin genes strongly depends on PCNAK164 modification. J Exp Med 204: 1989-1998.
39. Labi V, Erlacher M, Krumschnabel G, Manzl C, Tzankov A, et al. (2010) Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev 24: 1602-1607.
40. Michalak EM, Vandenberg CJ, Delbridge AR, Wu L, Scott CL, et al. (2010) Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev 24: 1608-1613.
41. Bartelt-Kirbach B, Wuepping M, Dodrimont-Lattke M, Kaufmann D, (2009) Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation. Neurogenetics 10: 79-85.
42. Cnossen MH, van der Est MN, Breuning MH, van Asperen CJ, Breslau-Siderius EJ, et al. (1997) Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1? Hum Mutat 9: 458-464.
43. Chines P, Swift A, Bonnycastle LL, Erdos MR, Mullikin J, et al. (2005) PrimerTile: designing overlapping PCR primers for resequencing. American Journal of Human Genetics 77: 1257.
44. Yamamoto K, Ishiai M, Matsushita N, Arakawa H, Lamerdin JE, et al. (2003) Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol Cell Biol 23: 5421-5430.
45. Ishiai M, Kimura M, Namikoshi K, Yamazoe M, Yamamoto K, et al. (2004) DNA cross-link repair protein SNM1A interacts with PIAS1 in nuclear focus formation. Mol Cell Biol 24: 10733-10741.
46. Kitao H, Kimura M, Yamamoto K, Seo H, Namikoshi K, et al. (2008) Regulation of histone H4 acetylation by transcription factor E2A in Ig gene conversion. Int Immunol 20: 277-284.
47. Kannouche PL, Wing J, Lehmann AR, (2004) Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol Cell 14: 491-500.
48. Ewing B, Green P, (1998) Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8: 186-194.
49. Ewing B, Hillier L, Wendl MC, Green P, (1998) Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8: 175-185.
50. Gordon D, Abajian C, Green P, (1998) Consed: a graphical tool for sequence finishing. Genome Res 8: 195-202.
51. Bhangale TR, Stephens M, Nickerson DA, (2006) Automating resequencing-based detection of insertion-deletion polymorphisms. Nat Genet 38: 1457-1462.
52. Yamamoto K, Hirano S, Ishiai M, Morishima K, Kitao H, et al. (2005) Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol Cell Biol 25: 34-43.